San Diego-based Viking Therapeutics marked alone as a serious competitor inside the weight loss drug industry in February following revealing promising knowledge from a mid-stage trial of experimental drug VK2735, which prompt it rivaled—and outperformed—Novo and Lilly drugs when pre